- Report
- August 2026
- 286 Pages
Global
From €5246EUR$5,850USD£4,498GBP
- Report
- August 2026
- 402 Pages
Global
From €5246EUR$5,850USD£4,498GBP
- Report
- August 2026
- 187 Pages
Global
From €5246EUR$5,850USD£4,498GBP
- Report
- August 2026
- 193 Pages
Global
From €5246EUR$5,850USD£4,498GBP
- Report
- July 2026
- 130 Pages
Global
From €4260EUR$4,750USD£3,653GBP
- Report
- July 2026
- 180 Pages
Global
From €4260EUR$4,750USD£3,653GBP
- Report
- April 2026
- 180 Pages
Global
From €4260EUR$4,750USD£3,653GBP
- Report
- April 2026
- 195 Pages
Global
From €4260EUR$4,750USD£3,653GBP
- Report
- April 2026
- 120 Pages
Global
From €4260EUR$4,750USD£3,653GBP
- Report
- May 2026
- 150 Pages
Global
From €3363EUR$3,750USD£2,884GBP
- Report
- January 2026
- 550 Pages
Global
From €4484EUR$5,000USD£3,845GBP
- Report
- November 2025
- 200 Pages
Global
From €7129EUR$7,950USD£6,113GBP
- Report
- May 2026
- 400 Pages
Global
From €4438EUR$4,949USD£3,806GBP
- Report
- May 2026
- 200 Pages
Global
From €2501EUR$2,789USD£2,145GBP
- Report
- May 2026
- 200 Pages
Global
From €2501EUR$2,789USD£2,145GBP
- Report
- April 2026
- 146 Pages
Global
From €2689EUR$2,999USD£2,306GBP
€3586EUR$3,999USD£3,075GBP
- Report
- January 2026
- 297 Pages
Global
From €2242EUR$2,500USD£1,922GBP
- Report
- July 2026
- 180 Pages
Global
From €4260EUR$4,750USD£3,653GBP
- Report
- April 2026
- 120 Pages
Global
From €4260EUR$4,750USD£3,653GBP
- Report
- May 2026
- 350 Pages
Global
From €4438EUR$4,949USD£3,806GBP

T Cell Therapies are a type of biotechnology that involves the use of a patient's own T cells to treat diseases. T cells are a type of white blood cell that play a key role in the body's immune system. T Cell Therapies involve the extraction of T cells from a patient, engineering them to recognize and attack specific targets, and then reintroducing them into the patient's body. This type of therapy has been used to treat a variety of cancers, including leukemia, lymphoma, and multiple myeloma. It has also been used to treat autoimmune diseases, such as rheumatoid arthritis and Crohn's disease.
T Cell Therapies are a rapidly growing field of biotechnology, with many companies investing in research and development. Companies such as Kite Pharma, Juno Therapeutics, and Novartis are leading the way in developing and commercializing T Cell Therapies. Other companies, such as Gilead Sciences, Celgene, and Regeneron, are also investing in the field. Show Less Read more